Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
filgrastim (neupogen) (1 trial)
sargramostim (leukine) (2 trials)
autologous bone marrow (1 trial)
cyclophosphamide (cytoxan) (8 trials)
docetaxel (taxotere) (1 trial)
doxorubicin (Doxil) (3 trials)
epirubicin (ellence) (1 trial)
fluorouracil (efudex) (7 trials)
goserelin (zoladex) (2 trials)
leuprolide (lupron) (2 trials)
naltrexone (revia) (7 trials)
peripheral blood hematopoietic cell (2 trials)
tamoxifen (nolvadex) (7 trials)
temsirolimus (torisel) (5 trials)
thiotepa (2 trials)
vinorelbine (navelbine) (5 trials)
Breast Neoplasms (Phase 4)
Inflammatory Breast Neoplasms (Phase 3)
Neutropenia (Phase 4)
Trials (9 total)
Trial APIs (16 total)